Sporadic Superficial and Nodular Skin Basal Cell Carcinomas
1 clinical trials · Condition
◉ Watch Sporadic Superficial and Nodular Skin Basal Cell Carcinomas
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC) (NCT01033019) | Novartis Pharmaceuticals | 2009-12-01 |
Track Sporadic Superficial and Nodular Skin Basal Cell Carcinomas automatically
Every clearance here is in the API, with alerts when new ones post.